Xamoterol (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Xamoterol" in English language version.

refsWebsite

Global rank English rank

9nih.gov

4^th place

5doi.org

2^nd place

2drugbank.com

low place

1fda.gov

447^th place

338^th place

1books.google.com

3^rd place

1chemspider.com

8,573^rd place

low place

books.google.com (Global: 3^rd place; English: 3^rd place)

Schweizerischer Apotheker-Verein (2000). Index Nominum 2000: International Drug Directory. Medpharm Scientific Publishers. p. 1099. ISBN 978-3-88763-075-1. Retrieved 23 July 2024.

chemspider.com (Global: 8,573^rd place; English: low place)

"Xamoterol [USAN:BAN:INN]". ChemSpider. 21 July 2022. Retrieved 1 August 2024.

doi.org (Global: 2^nd place; English: 2^nd place)

Furlong R, Brogden RN (October 1988). "Xamoterol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use". Drugs. 36 (4): 455–474. doi:10.2165/00003495-198836040-00004. PMID 2906865.
Marlow HF (1989). "Xamoterol, a beta 1-adrenoceptor partial agonist: review of the clinical efficacy in heart failure". British Journal of Clinical Pharmacology. 28 (Suppl 1): 23S–30S. doi:10.1111/j.1365-2125.1989.tb03570.x. PMC 1379873. PMID 2572251.
Campbell RW (1989). "The management of heart failure and the scope for new therapies: what role for xamoterol?". Br J Clin Pharmacol. 28 Suppl 1 (Suppl 1): 59S–64S. doi:10.1111/j.1365-2125.1989.tb03574.x. PMC 1379877. PMID 2572256.
Cruickshank JM (March 1993). "The xamoterol experience in the treatment of heart failure". Am J Cardiol. 71 (9): 61C–64C. doi:10.1016/0002-9149(93)90088-t. PMID 8465800.
Vigholt-Sørensen E, Faergeman O, Snow HM (November 1989). "Effects of xamoterol, a beta 1 adrenoceptor partial agonist, in patients with ischaemic dysfunction of the left ventricle". Br Heart J. 62 (5): 335–341. doi:10.1136/hrt.62.5.335. PMC 1224831. PMID 2574049.

drugbank.com (Global: low place; English: low place)

go.drugbank.com

"Xamoterol: Uses, Interactions, Mechanism of Action". DrugBank Online. 23 June 2017. Retrieved 23 July 2024.
"Xamoterol: Uses, Interactions, Mechanism of Action". DrugBank Online. 23 June 2017. Retrieved 1 August 2024.

fda.gov (Global: 447^th place; English: 338^th place)

accessdata.fda.gov

"Drugs@FDA: FDA-Approved Drugs". accessdata.fda.gov. Retrieved 23 July 2024.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Furlong R, Brogden RN (October 1988). "Xamoterol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use". Drugs. 36 (4): 455–474. doi:10.2165/00003495-198836040-00004. PMID 2906865.
Marlow HF (1989). "Xamoterol, a beta 1-adrenoceptor partial agonist: review of the clinical efficacy in heart failure". British Journal of Clinical Pharmacology. 28 (Suppl 1): 23S–30S. doi:10.1111/j.1365-2125.1989.tb03570.x. PMC 1379873. PMID 2572251.
Campbell RW (1989). "The management of heart failure and the scope for new therapies: what role for xamoterol?". Br J Clin Pharmacol. 28 Suppl 1 (Suppl 1): 59S–64S. doi:10.1111/j.1365-2125.1989.tb03574.x. PMC 1379877. PMID 2572256.
Cruickshank JM (March 1993). "The xamoterol experience in the treatment of heart failure". Am J Cardiol. 71 (9): 61C–64C. doi:10.1016/0002-9149(93)90088-t. PMID 8465800.
Vigholt-Sørensen E, Faergeman O, Snow HM (November 1989). "Effects of xamoterol, a beta 1 adrenoceptor partial agonist, in patients with ischaemic dysfunction of the left ventricle". Br Heart J. 62 (5): 335–341. doi:10.1136/hrt.62.5.335. PMC 1224831. PMID 2574049.

ncbi.nlm.nih.gov

Marlow HF (1989). "Xamoterol, a beta 1-adrenoceptor partial agonist: review of the clinical efficacy in heart failure". British Journal of Clinical Pharmacology. 28 (Suppl 1): 23S–30S. doi:10.1111/j.1365-2125.1989.tb03570.x. PMC 1379873. PMID 2572251.
Campbell RW (1989). "The management of heart failure and the scope for new therapies: what role for xamoterol?". Br J Clin Pharmacol. 28 Suppl 1 (Suppl 1): 59S–64S. doi:10.1111/j.1365-2125.1989.tb03574.x. PMC 1379877. PMID 2572256.
Vigholt-Sørensen E, Faergeman O, Snow HM (November 1989). "Effects of xamoterol, a beta 1 adrenoceptor partial agonist, in patients with ischaemic dysfunction of the left ventricle". Br Heart J. 62 (5): 335–341. doi:10.1136/hrt.62.5.335. PMC 1224831. PMID 2574049.

pubchem.ncbi.nlm.nih.gov

"Xamoterol". PubChem. Retrieved 1 August 2024.